Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Identification of novel, immune-mediating extracellular vesicles in human lymphatic effluent draining primary cutaneous melanoma.

Maus RLG, Jakub JW, Hieken TJ, Nevala WK, Christensen TA, Sutor SL, Flotte TJ, Markovic SN.

Oncoimmunology. 2019 Sep 30;8(12):e1667742. doi: 10.1080/2162402X.2019.1667742. eCollection 2019.

2.

Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistance.

Walker AJ, Price JB, Borreggine K, Sutor SL, Gogos A, McGillivray JA, Frye MA, Tye SJ.

Transl Psychiatry. 2019 Mar 15;9(1):113. doi: 10.1038/s41398-019-0434-5.

3.

CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment.

Enninga EAL, Chatzopoulos K, Butterfield JT, Sutor SL, Leontovich AA, Nevala WK, Flotte TJ, Markovic SN.

J Pathol. 2018 Aug;245(4):468-477. doi: 10.1002/path.5093. Epub 2018 Jun 28.

PMID:
29732570
4.

Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20+ B-cell lymphoma.

Nevala WK, Butterfield JT, Sutor SL, Knauer DJ, Markovic SN.

Sci Rep. 2017 Apr 5;7:45682. doi: 10.1038/srep45682.

5.

Heat Stress-Induced PI3K/mTORC2-Dependent AKT Signaling Is a Central Mediator of Hepatocellular Carcinoma Survival to Thermal Ablation Induced Heat Stress.

Thompson SM, Callstrom MR, Jondal DE, Butters KA, Knudsen BE, Anderson JL, Lien KR, Sutor SL, Lee JS, Thorgeirsson SS, Grande JP, Roberts LR, Woodrum DA.

PLoS One. 2016 Sep 9;11(9):e0162634. doi: 10.1371/journal.pone.0162634. eCollection 2016.

6.

Antidepressant actions of lateral habenula deep brain stimulation differentially correlate with CaMKII/GSK3/AMPK signaling locally and in the infralimbic cortex.

Kim Y, Morath B, Hu C, Byrne LK, Sutor SL, Frye MA, Tye SJ.

Behav Brain Res. 2016 Jun 1;306:170-7. doi: 10.1016/j.bbr.2016.02.039. Epub 2016 Mar 5.

PMID:
26956153
7.

Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance.

Walker AJ, Foley BM, Sutor SL, McGillivray JA, Frye MA, Tye SJ.

Behav Brain Res. 2015 Oct 15;293:198-202. doi: 10.1016/j.bbr.2015.07.026. Epub 2015 Jul 21.

PMID:
26209292
8.

Generation and sequencing of pulmonary carcinoid tumor cell lines.

Asiedu MK, Thomas CF Jr, Tomaszek SC, Peikert T, Sanyal B, Sutor SL, Aubry MC, Li P, Wigle DA.

J Thorac Oncol. 2014 Dec;9(12):1763-71. doi: 10.1097/JTO.0000000000000339.

9.
10.

Role for putative hepatocellular carcinoma stem cell subpopulations in biological response to incomplete thermal ablation: in vitro and in vivo pilot study.

Thompson SM, Callstrom MR, Butters KA, Sutor SL, Knudsen B, Grande JP, Roberts LR, Woodrum DA.

Cardiovasc Intervent Radiol. 2014 Oct;37(5):1343-51. doi: 10.1007/s00270-013-0828-3. Epub 2014 Jan 23.

11.

ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status.

Huntoon CJ, Flatten KS, Wahner Hendrickson AE, Huehls AM, Sutor SL, Kaufmann SH, Karnitz LM.

Cancer Res. 2013 Jun 15;73(12):3683-91. doi: 10.1158/0008-5472.CAN-13-0110. Epub 2013 Apr 2.

12.

Molecular bioluminescence imaging as a noninvasive tool for monitoring tumor growth and therapeutic response to MRI-guided laser ablation in a rat model of hepatocellular carcinoma.

Thompson SM, Callstrom MR, Knudsen BE, Anderson JL, Sutor SL, Butters KA, Kuo C, Grande JP, Roberts LR, Woodrum DA.

Invest Radiol. 2013 Jun;48(6):413-21. doi: 10.1097/RLI.0b013e31827a4a3f.

13.

Severe osteogenesis imperfecta in cyclophilin B-deficient mice.

Choi JW, Sutor SL, Lindquist L, Evans GL, Madden BJ, Bergen HR 3rd, Hefferan TE, Yaszemski MJ, Bram RJ.

PLoS Genet. 2009 Dec;5(12):e1000750. doi: 10.1371/journal.pgen.1000750. Epub 2009 Dec 4.

14.

Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease.

Murali NS, Ackerman AW, Croatt AJ, Cheng J, Grande JP, Sutor SL, Bram RJ, Bren GD, Badley AD, Alam J, Nath KA.

Am J Physiol Renal Physiol. 2007 Feb;292(2):F837-44. Epub 2006 Sep 12.

15.

Selective activation of TACI by syndecan-2.

Bischof D, Elsawa SF, Mantchev G, Yoon J, Michels GE, Nilson A, Sutor SL, Platt JL, Ansell SM, von Bulow G, Bram RJ.

Blood. 2006 Apr 15;107(8):3235-42. Epub 2005 Dec 15.

16.

CAML is a p56Lck-interacting protein that is required for thymocyte development.

Tran DD, Edgar CE, Heckman KL, Sutor SL, Huntoon CJ, van Deursen J, McKean DL, Bram RJ.

Immunity. 2005 Aug;23(2):139-52.

17.

CAML is required for efficient EGF receptor recycling.

Tran DD, Russell HR, Sutor SL, van Deursen J, Bram RJ.

Dev Cell. 2003 Aug;5(2):245-56.

18.

Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-gamma1 and Ras activation.

Williams BL, Irvin BJ, Sutor SL, Chini CC, Yacyshyn E, Bubeck Wardenburg J, Dalton M, Chan AC, Abraham RT.

EMBO J. 1999 Apr 1;18(7):1832-44.

19.

A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf.

Sutor SL, Vroman BT, Armstrong EA, Abraham RT, Karnitz LM.

J Biol Chem. 1999 Mar 12;274(11):7002-10.

20.

Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway.

Karnitz LM, Burns LA, Sutor SL, Blenis J, Abraham RT.

Mol Cell Biol. 1995 Jun;15(6):3049-57.

21.
22.

Interleukin-2-induced tyrosine phosphorylation of p52shc in T lymphocytes.

Burns LA, Karnitz LM, Sutor SL, Abraham RT.

J Biol Chem. 1993 Aug 25;268(24):17659-61.

23.
24.

Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line.

Karnitz L, Sutor SL, Torigoe T, Reed JC, Bell MP, McKean DJ, Leibson PJ, Abraham RT.

Mol Cell Biol. 1992 Oct;12(10):4521-30.

Supplemental Content

Loading ...
Support Center